OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia
Rashidul Alam Mahumud, Khorshed Alam, Jeff Dunn, et al.
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0223658-e0223658
Open Access | Times Cited: 12
Rashidul Alam Mahumud, Khorshed Alam, Jeff Dunn, et al.
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0223658-e0223658
Open Access | Times Cited: 12
Showing 12 citing articles:
Technologically scaffolded atypical cognition: the case of YouTube’s recommender system
Mark Alfano, Amir Ebrahimi Fard, J. Adam Carter, et al.
Synthese (2020) Vol. 199, Iss. 1-2, pp. 835-858
Open Access | Times Cited: 88
Mark Alfano, Amir Ebrahimi Fard, J. Adam Carter, et al.
Synthese (2020) Vol. 199, Iss. 1-2, pp. 835-858
Open Access | Times Cited: 88
Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model
Liangru Zhou, Baiyang Gu, Jian Wang, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Liangru Zhou, Baiyang Gu, Jian Wang, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Modelling epidemiological and economics processes – the case of cervical cancer
F Taeger, Lena Mende, Steffen Fleßa
Health Economics Review (2025) Vol. 15, Iss. 1
Open Access
F Taeger, Lena Mende, Steffen Fleßa
Health Economics Review (2025) Vol. 15, Iss. 1
Open Access
Recommendations for prevention of infection in systemic autoimmune rheumatic diseases
Íñigo Rúa-Figueroa Fernández de Larrinoa, Patrícia Carreira, Noé Brito García, et al.
Reumatología Clínica (English Edition) (2021) Vol. 18, Iss. 6, pp. 317-330
Closed Access | Times Cited: 9
Íñigo Rúa-Figueroa Fernández de Larrinoa, Patrícia Carreira, Noé Brito García, et al.
Reumatología Clínica (English Edition) (2021) Vol. 18, Iss. 6, pp. 317-330
Closed Access | Times Cited: 9
Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines
Madison C. Silver, Peter J. Neumann, Siyu Ma, et al.
Vaccine (2021) Vol. 39, Iss. 46, pp. 6727-6734
Closed Access | Times Cited: 9
Madison C. Silver, Peter J. Neumann, Siyu Ma, et al.
Vaccine (2021) Vol. 39, Iss. 46, pp. 6727-6734
Closed Access | Times Cited: 9
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong
Tak Hong Cheung, Sally Shuk Yee Cheng, Danny Hsu, et al.
Cost Effectiveness and Resource Allocation (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Tak Hong Cheung, Sally Shuk Yee Cheng, Danny Hsu, et al.
Cost Effectiveness and Resource Allocation (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
Kris Doggen, Albert Jan van Hoek, Jeroen Luyten
PharmacoEconomics (2023) Vol. 41, Iss. 5, pp. 481-497
Closed Access | Times Cited: 2
Kris Doggen, Albert Jan van Hoek, Jeroen Luyten
PharmacoEconomics (2023) Vol. 41, Iss. 5, pp. 481-497
Closed Access | Times Cited: 2
Are intersectoral costs considered in economic evaluations of interventions relating to sexually transmitted infections (STIs)? A systematic review
Lena Schnitzler, Silvia M. A. A. Evers, Louise Jackson, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Lena Schnitzler, Silvia M. A. A. Evers, Louise Jackson, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Recombinant adenoviruses expressing HPV16/18 E7 upregulate the HDAC6 and DNMT3B genes in C33A cells
Y.Y. Shao, Pir Tariq Shah, Qisheng Su, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Y.Y. Shao, Pir Tariq Shah, Qisheng Su, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas
Íñigo Rúa-Figueroa Fernández de Larrinoa, Patrícia Carreira, Noé Brito García, et al.
Reumatología Clínica (2021) Vol. 18, Iss. 6, pp. 317-330
Closed Access | Times Cited: 4
Íñigo Rúa-Figueroa Fernández de Larrinoa, Patrícia Carreira, Noé Brito García, et al.
Reumatología Clínica (2021) Vol. 18, Iss. 6, pp. 317-330
Closed Access | Times Cited: 4
The Cost-Effectiveness of HPV Vaccination in Asia Pacific Countries: What Lessons Can Indonesia Learn? – A Systematic Review
Suzanna Mongan, Joshua Byrnes, Han‐Soo Kim
(2024)
Closed Access
Suzanna Mongan, Joshua Byrnes, Han‐Soo Kim
(2024)
Closed Access
Correction: The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia
Rashidul Alam Mahumud, Khorshed Alam, Jeff Dunn, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295688-e0295688
Open Access
Rashidul Alam Mahumud, Khorshed Alam, Jeff Dunn, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295688-e0295688
Open Access
